Jump to Content
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Current issue All issues Accepted manuscripts Special Collections Special issues
Submit now How to submit Author guidelines Reasons to publish Peer review Research data Ethical policy Open-access policy Post-publication changes Publication charges Author resource centre
Subscribe
Contact the journal About Endocrine-Related Cancer Scope Editorial board Societies For libraries Abstracting and indexing Vacancy closed: Editor-in-Chief
Alerts Journals
Advanced Search Help
Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo Endocrine-Related Cancer journal logo
Society for Endocrinology logo
Sign in Create account
Home Browse
Current issue All issues Accepted manuscripts Special Collections Special issues
Submit now How to submit Author guidelines Reasons to publish Peer review Research data Ethical policy Open-access policy Post-publication changes Publication charges Author resource centre
Subscribe
Contact the journal About Endocrine-Related Cancer Scope Editorial board Societies For libraries Abstracting and indexing Vacancy closed: Editor-in-Chief
Alerts Journals
Advanced Search Help

Volume 28 (2021): Issue 3 (Mar 2021)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-0088

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

Sign up using the button to receive email notifications of the latest research.

Sign up for journal news
Review
Somatostatin receptor radionuclide therapy in neuroendocrine tumors
Research
Diagnostic and management strategies for pNETs in Von Hippel–Lindau: a systematic review
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
Leptin-elicited PBX3 confers letrozole resistance in breast cancer
Exercise intensity and markers of inflammation during and after (neo-) adjuvant cancer treatment
A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy
Transcriptomic landscape of radiation-induced murine thyroid proliferative lesions
Letter
Thyroid nodules with indeterminate cytology: is it safe to say ‘thyroidectomy can be excluded if 18F-FDG-PET suggests benignity’?
Response to Letter to the Editor: Thyroid nodules with indeterminate cytology: is it safe to say ‘thyroidectomy can be excluded if 18F-FDG-PET suggests benignity’?
  • Save
  • Collapse
  • Expand
  • Top
Print ISSN:
1351-0088
Online ISSN:
1479-6821

Online ISSN: 1479-6821
Print ISSN: 1351-0088

Follow the journal on Twitter

Author Information

Author Guidelines

Open Access Policy

Permissions

Librarian Information

General Information

Products and Prices

Read and Publish Deal

General Information

Contact the journal

Advertising

Help

Bioscientifica logo

Strengthening biomedical communities
to advance science and health

 

Accessibility

Privacy and Cookies

Terms and Conditions

 

About Bioscientifica

All Bioscientifica Journals

Publishing Alliances

 

CONTACT US

Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK

Bioscientifica Ltd | Registered in England no 3190519

© 2024 Bioscientifica Ltd
Powered by PubFactory
  • [18.97.14.91]
  • 18.97.14.91
Close
Edit

Character limit 500/500

@!

Character limit 500/500